Literature DB >> 30355800

Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis.

Nicholas A Scott1,2, Anna Andrusaite3, Peter Andersen4, Melissa Lawson5, Cristina Alcon-Giner5, Charlotte Leclaire5, Shabhonam Caim5, Gwenaelle Le Gall5, Tovah Shaw1,2, James P R Connolly3, Andrew J Roe3, Hannah Wessel3, Alberto Bravo-Blas3, Carolyn A Thomson3, Verena Kästele3, Ping Wang1, Daniel A Peterson4,6, Allison Bancroft1,7, Xuhang Li4, Richard Grencis1,7, Allan McI Mowat3, Lindsay J Hall5, Mark A Travis1,2,7, Simon W F Milling3, Elizabeth R Mann8,2,3.   

Abstract

Macrophages in the healthy intestine are highly specialized and usually respond to the gut microbiota without provoking an inflammatory response. A breakdown in this tolerance leads to inflammatory bowel disease (IBD), but the mechanisms by which intestinal macrophages normally become conditioned to promote microbial tolerance are unclear. Strong epidemiological evidence linking disruption of the gut microbiota by antibiotic use early in life to IBD indicates an important role for the gut microbiota in modulating intestinal immunity. Here, we show that antibiotic use causes intestinal macrophages to become hyperresponsive to bacterial stimulation, producing excess inflammatory cytokines. Re-exposure of antibiotic-treated mice to conventional microbiota induced a long-term, macrophage-dependent increase in inflammatory T helper 1 (TH1) responses in the colon and sustained dysbiosis. The consequences of this dysregulated macrophage activity for T cell function were demonstrated by increased susceptibility to infections requiring TH17 and TH2 responses for clearance (bacterial Citrobacter rodentium and helminth Trichuris muris infections), corresponding with increased inflammation. Short-chain fatty acids (SCFAs) were depleted during antibiotic administration; supplementation of antibiotics with the SCFA butyrate restored the characteristic hyporesponsiveness of intestinal macrophages and prevented T cell dysfunction. Butyrate altered the metabolic behavior of macrophages to increase oxidative phosphorylation and also promoted alternative macrophage activation. In summary, the gut microbiota is essential to maintain macrophage-dependent intestinal immune homeostasis, mediated by SCFA-dependent pathways. Oral antibiotics disrupt this process to promote sustained T cell-mediated dysfunction and increased susceptibility to infections, highlighting important implications of repeated broad-spectrum antibiotic use.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30355800      PMCID: PMC6548564          DOI: 10.1126/scitranslmed.aao4755

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  60 in total

1.  CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease.

Authors:  Susanne Thiesen; Sabina Janciauskiene; Heli Uronen-Hansson; William Agace; Carl-Magnus Högerkorp; Pieter Spee; Katarina Håkansson; Olof Grip
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

2.  Integrative analysis of environmental sequences using MEGAN4.

Authors:  Daniel H Huson; Suparna Mitra; Hans-Joachim Ruscheweyh; Nico Weber; Stephan C Schuster
Journal:  Genome Res       Date:  2011-06-20       Impact factor: 9.043

3.  Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production.

Authors:  C Hessle; L A Hanson; A E Wold
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

Review 4.  Summer Meeting 2013: growth and physiology of bifidobacteria.

Authors:  L De Vuyst; F Moens; M Selak; A Rivière; F Leroy
Journal:  J Appl Microbiol       Date:  2013-12-20       Impact factor: 3.772

5.  Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria.

Authors:  Usriansyah Hadis; Benjamin Wahl; Olga Schulz; Matthias Hardtke-Wolenski; Angela Schippers; Norbert Wagner; Werner Müller; Tim Sparwasser; Reinhold Förster; Oliver Pabst
Journal:  Immunity       Date:  2011-02-17       Impact factor: 31.745

6.  Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.

Authors:  Dror S Shouval; Amlan Biswas; Yu Hui Kang; Alexandra E Griffith; Liza Konnikova; Ivan D Mascanfroni; Naresh S Redhu; Sandra M Frei; Michael Field; Andria L Doty; Jeffrey D Goldsmith; Atul K Bhan; Anthony Loizides; Batia Weiss; Baruch Yerushalmi; Tadahiro Yanagi; Xiuli Lui; Francisco J Quintana; Aleixo M Muise; Christoph Klein; Bruce H Horwitz; Sarah C Glover; Athos Bousvaros; Scott B Snapper
Journal:  Gastroenterology       Date:  2016-09-28       Impact factor: 22.682

7.  Antibiotic exposure and IBD development among children: a population-based cohort study.

Authors:  Matthew P Kronman; Theoklis E Zaoutis; Kevin Haynes; Rui Feng; Susan E Coffin
Journal:  Pediatrics       Date:  2012-09-24       Impact factor: 7.124

8.  Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.

Authors:  Kim O Gradel; Hans L Nielsen; Henrik C Schønheyder; Tove Ejlertsen; Brian Kristensen; Henrik Nielsen
Journal:  Gastroenterology       Date:  2009-04-08       Impact factor: 22.682

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

Review 10.  Metabolic reprograming in macrophage polarization.

Authors:  Silvia Galván-Peña; Luke A J O'Neill
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561

View more
  53 in total

1.  Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity.

Authors:  Mathilde Payen; Ioannis Nicolis; Marie Robin; David Michonneau; Johanne Delannoye; Camille Mayeur; Nathalie Kapel; Béatrice Berçot; Marie-José Butel; Jérôme Le Goff; Gérard Socié; Clotilde Rousseau
Journal:  Blood Adv       Date:  2020-05-12

2.  Microbiota-independent antiviral effects of antibiotics on poliovirus and coxsackievirus.

Authors:  Mikal A Woods Acevedo; Julie K Pfeiffer
Journal:  Virology       Date:  2020-04-08       Impact factor: 3.616

Review 3.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

4.  Gut microbiota can affect bone quality by regulating serum estrogen levels.

Authors:  Xing Guo; Kai Zhong; Jianhua Zhang; Lv Hui; Longfei Zou; Hao Xue; Jiang Guo; Shuling Zheng; Denghua Huang; Meiyun Tan
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

5.  Integrated Analysis of the Alterations in Gut Microbiota and Metabolites of Mice Induced After Long-Term Intervention With Different Antibiotics.

Authors:  Nan Zhang; Jun Liu; Zhiyun Chen; Ning Chen; Fangyan Gu; Qiushui He
Journal:  Front Microbiol       Date:  2022-06-29       Impact factor: 6.064

6.  Post-antibiotic gut dysbiosis-induced trabecular bone loss is dependent on lymphocytes.

Authors:  Naiomy Deliz Rios-Arce; Jonathan D Schepper; Andrew Dagenais; Laura Schaefer; Connor S Daly-Seiler; Joseph D Gardinier; Robert A Britton; Laura R McCabe; Narayanan Parameswaran
Journal:  Bone       Date:  2020-02-21       Impact factor: 4.398

Review 7.  Molecular mechanisms of probiotic prevention of antibiotic-associated diarrhea.

Authors:  Solomon A Mekonnen; Daniel Merenstein; Claire M Fraser; Maria L Marco
Journal:  Curr Opin Biotechnol       Date:  2020-02-19       Impact factor: 9.740

Review 8.  Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD.

Authors:  Yi Rang Na; Michelle Stakenborg; Seung Hyeok Seok; Gianluca Matteoli
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-16       Impact factor: 46.802

Review 9.  Complex interactions between the microbiome and cancer immune therapy.

Authors:  Drew J Schwartz; Olivia N Rebeck; Gautam Dantas
Journal:  Crit Rev Clin Lab Sci       Date:  2019-09-17       Impact factor: 6.250

Review 10.  Epigenome-metabolome-microbiome axis in health and IBD.

Authors:  Hajera Amatullah; Kate L Jeffrey
Journal:  Curr Opin Microbiol       Date:  2020-09-10       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.